APA (7th ed.) Citation

Marcia S. C. Melhem, Vivian C. Coelho, Claudia A. Fonseca, Lidiane de Oliveira, Lucas X. Bonfietti, Maria. W. Szeszs, . . . Maria A. Shikanai-Yasuda. (2022). Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against <i>Aspergillus</i><i>fumigatus</i> and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values. MDPI AG.

Chicago Style (17th ed.) Citation

Marcia S. C. Melhem, et al. Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, Against <i>Aspergillus</i><i>fumigatus</i> and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values. MDPI AG, 2022.

MLA (9th ed.) Citation

Marcia S. C. Melhem, et al. Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, Against <i>Aspergillus</i><i>fumigatus</i> and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values. MDPI AG, 2022.